SCHEMBL8087155

SCHEMBL8087155

O=C(O)CC1=C[N]c2ccccc21

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1B1 P15121 4/20 0.42
LMNA P02545 2/20 0.37
ABCC4 O15439 1/20 0.37
GAA P10253 1/20 0.37
TSHR P16473 1/20 0.37
PTGS1 P23219 1/20 0.37
HTT P42858 1/20 0.37
CA12 O43570 1/20 0.35
CA9 Q16790 1/20 0.35
FFAR1 O14842 1/20 0.34
NAPRT Q6XQN6 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
CES2 O00748 1/20 0.33
CES1 P23141 1/20 0.33
APEX1 P27695 1/20 0.33
NR4A2 P43354 1/20 0.33
KDM4E B2RXH2 1/20 0.33
ALDH1A1 P00352 1/20 0.33
RXFP1 Q9HBX9 1/20 0.33
CDC25B P30305 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8086972 0.80 HSD17B10 (0.43) LMNATSHRHTTCA12CA9
SCHEMBL8078829 0.71 ALDH1A1 (0.36) LMNATSHRCA12CA9NAPRT
SCHEMBL2012366 0.68 IDO1 (0.37) AKR1B1LMNAABCC4GAATSHR
SCHEMBL9754870 0.68 ALDH1A1 (0.39) TSHRKDM4EALDH1A1
SCHEMBL8488065 0.67 AKR1B1 (0.46) AKR1B1LMNAABCC4GAATSHR
SCHEMBL27848247 0.65 PTPN1 (0.50) AKR1B1LMNAABCC4GAATSHR
SCHEMBL3096746 0.65 APAF1 (0.33) LMNATSHRCA12TDP1APEX1
SCHEMBL7827157 0.65 AKR1B1 (0.67) AKR1B1LMNAABCC4GAATSHR
Phenylacetic Acid SCHEMBL28218631 0.64 AKR1B1 (0.94) AKR1B1LMNAABCC4GAATSHR
SCHEMBL11096875 0.63 AKR1B1 (0.38) AKR1B1LMNAABCC4GAATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6080743-A AS CHEMICAL INTERMEIDATES FOR PREPARING DRUGS NOVARTIS AG (CH) 2000-06-27 US disclosed
EP-0853617-A1 NOVEL 2,3-DIOXO-1,2,3,4-TETRAHYDRO-QUINOYXALINYL DERIVATIVES Novartis AG (CH) 1998-07-22 EP disclosed
WO-1997008155-A1 NOVEL 2,3-DIOXO-1,2,3,4-TETRAHYDRO-QUINOYXALINYL DERIVATIVES NOVARTIS AG (CH) 1997-03-06 WO disclosed